Drug development progress in duchenne muscular dystrophy

J Deng, J Zhang, K Shi, Z Liu - Frontiers in Pharmacology, 2022 - frontiersin.org
Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked
disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of …

Update on clinical trials of losartan with and without β-blockers to block aneurysm growth in patients with Marfan syndrome: a review

MAH Bowman, KA Eagle, DM Milewicz - JAMA cardiology, 2019 - jamanetwork.com
Importance Thoracic aortic aneurysms leading to acute aortic dissections are a major cause
of morbidity and mortality despite significant advances in surgical treatment, which remains …

In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice

M El Refaey, L Xu, Y Gao, BD Canan… - Circulation …, 2017 - Am Heart Assoc
Rationale: Duchenne muscular dystrophy is a severe inherited form of muscular dystrophy
caused by mutations in the reading frame of the dystrophin gene disrupting its protein …

Advances in stem cell modeling of dystrophin-associated disease: implications for the wider world of dilated cardiomyopathy

JM Pioner, A Fornaro, R Coppini, N Ceschia… - Frontiers in …, 2020 - frontiersin.org
Familial dilated cardiomyopathy (DCM) is mostly caused by mutations in genes encoding
cytoskeletal and sarcomeric proteins. In the pediatric population, DCM is the predominant …

Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy

A Nikhanj, B Miskew Nichols, K Wang… - … Journal-Quality of …, 2021 - academic.oup.com
Aims Heart disease is recognized as the leading cause of morbidity and mortality in patients
with muscular dystrophy (MD). Our study demonstrates the clinical utility of cardiac …

Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy

J Deng, F Liu, Z Feng, Z Liu - CPT: Pharmacometrics & Systems …, 2024 - Wiley Online Library
Duchenne muscular dystrophy (DMD) is a rare X‐linked recessive disorder characterized by
loss‐of‐function mutations in the gene encoding dystrophin. These mutations lead to …

Developing a natural history model for Duchenne muscular dystrophy

J Broomfield, M Hill, F Chandler, MJ Crowther… - PharmacoEconomics …, 2024 - Springer
Background The aim of this study was to pool multiple data sets to build a patient-centric,
data-informed, natural history model (NHM) for Duchenne muscular dystrophy (DMD) to …

Health profile of preterm males with Duchenne muscular dystrophy

A Soim, B Wallace, N Whitehead… - Journal of child …, 2021 - journals.sagepub.com
In this retrospective cohort study, we characterize the health profile of preterm males with
Duchenne muscular dystrophy. Major clinical milestones (ambulation cessation, assisted …

Understanding heart disease in patients with muscular dystrophy

A Nikhanj - 2022 - era.library.ualberta.ca
Background Muscular dystrophy (MD) is a group of inherited neuromuscular disorders with
heart disease as a leading cause of morbidity and mortality. Dystrophinopathies such as …

Initial Diagnostic Evaluation of the Child With Suspected Arterial Ischemic Stroke

M Negrotto, P Muthusami, BA Wasserman… - Topics in Magnetic …, 2021 - journals.lww.com
Numerous factors make the initial diagnostic evaluation of children with suspected arterial
ischemic stroke (AIS) a relatively unsettling challenge, even for the experienced stroke …